253 related articles for article (PubMed ID: 31560840)
1. Thyroid dose-volume thresholds for the risk of radiation-related hypothyroidism in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy-A single-institution study.
Huang CL; Tan HW; Guo R; Zhang Y; Peng H; Peng L; Lin AH; Mao YP; Sun Y; Ma J; Tang LL
Cancer Med; 2019 Nov; 8(16):6887-6893. PubMed ID: 31560840
[TBL] [Abstract][Full Text] [Related]
2. Thyroid V40 Predicts Primary Hypothyroidism After Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma.
Sommat K; Ong WS; Hussain A; Soong YL; Tan T; Wee J; Fong KW
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):574-580. PubMed ID: 28581397
[TBL] [Abstract][Full Text] [Related]
3. Thyroid V
Zhou L; Chen J; Shen W; Chen ZL; Huang S; Tao CJ; Chen M; Yu ZH; Chen YY
Radiat Oncol; 2020 Mar; 15(1):68. PubMed ID: 32293496
[TBL] [Abstract][Full Text] [Related]
4. Pattern of radiation-induced thyroid gland changes in nasopharyngeal carcinoma patients in 48 months after radiotherapy.
Lin Z; Yang Z; He B; Wang D; Gao X; Tam SY; Wu VWC
PLoS One; 2018; 13(7):e0200310. PubMed ID: 29985952
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric Predictors of Hypothyroidism After Radical Intensity-modulated Radiation Therapy for Non-metastatic Nasopharyngeal Carcinoma.
Lee V; Chan SY; Choi CW; Kwong D; Lam KO; Tong CC; Sze CK; Ng S; Leung TW; Lee A
Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):e52-60. PubMed ID: 27235379
[TBL] [Abstract][Full Text] [Related]
6. Radiation-induced hypothyroidism after IMRT for nasopharyngeal carcinoma: Clinical and dosimetric predictors in a prospective cohort study.
Zhai RP; Kong FF; Du CR; Hu CS; Ying HM
Oral Oncol; 2017 May; 68():44-49. PubMed ID: 28438291
[TBL] [Abstract][Full Text] [Related]
7. Predictors of radiation-induced hypothyroidism in nasopharyngeal carcinoma survivors after intensity-modulated radiotherapy.
Zhai R; Lyu Y; Ni M; Kong F; Du C; Hu C; Ying H
Radiat Oncol; 2022 Mar; 17(1):57. PubMed ID: 35313921
[TBL] [Abstract][Full Text] [Related]
8. Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients.
Lu L; Sheng Y; Zhang G; Li Y; OuYang PY; Ge Y; Xie T; Chang H; Deng X; Wu JQ
Oral Oncol; 2018 Oct; 85():8-14. PubMed ID: 30220323
[TBL] [Abstract][Full Text] [Related]
9. Radiation-induced hypothyroidism in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy with or without chemotherapy: Development of a nomogram based on the equivalent dose.
Zhu MY; Wu HJ; Miao JJ; Di MP; Chen BY; Huang HG; Mai HQ; Wang L; Zhao C
Oral Oncol; 2021 Sep; 120():105378. PubMed ID: 34174518
[TBL] [Abstract][Full Text] [Related]
10. Thyroid V40 is a good predictor for subclinical hypothyroidism in patients with nasopharyngeal carcinoma after intensity modulated radiation therapy: a randomized clinical trial.
Xu Y; Peng H; Su G; Cheng Y; Guo Q; Guo L; Peng XE; Ke J
Radiat Oncol; 2023 Aug; 18(1):141. PubMed ID: 37626342
[TBL] [Abstract][Full Text] [Related]
11. Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer.
Diaz R; Jaboin JJ; Morales-Paliza M; Koehler E; Phillips JG; Stinson S; Gilbert J; Chung CH; Murphy BA; Yarbrough WG; Murphy PB; Shyr Y; Cmelak AJ
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):468-76. PubMed ID: 19577867
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study.
Huang J; Kong FF; Oei RW; Zhai RP; Hu CS; Ying HM
Radiat Oncol; 2019 Feb; 14(1):31. PubMed ID: 30736809
[TBL] [Abstract][Full Text] [Related]
13. Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship.
Chow JCH; Cheung KM; Au KH; Zee BCY; Lee J; Ngan RKC; Lee AWM; Yiu HHY; Li KWS; Leung AKC; Chan JCH; Lee FKH; Wong KH
Radiother Oncol; 2019 Sep; 138():93-98. PubMed ID: 31252300
[TBL] [Abstract][Full Text] [Related]
14. Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients.
Luo R; Wu VWC; He B; Gao X; Xu Z; Wang D; Yang Z; Li M; Lin Z
BMC Cancer; 2018 May; 18(1):575. PubMed ID: 29776390
[TBL] [Abstract][Full Text] [Related]
15. Validation of previously reported predictors for radiation-induced hypothyroidism in nasopharyngeal cancer patients treated with intensity-modulated radiation therapy, a post hoc analysis from a Phase III randomized trial.
Lertbutsayanukul C; Kitpanit S; Prayongrat A; Kannarunimit D; Netsawang B; Chakkabat C
J Radiat Res; 2018 Jul; 59(4):446-455. PubMed ID: 29750261
[TBL] [Abstract][Full Text] [Related]
16. Radiation-induced nasopharyngeal ulcers after intensity modulated radiotherapy in primary nasopharyngeal carcinoma patients: A dose-volume-outcome analysis.
Li Y; Xu T; Qian W; Lu X; Hu C
Oral Oncol; 2018 Sep; 84():1-6. PubMed ID: 30115466
[TBL] [Abstract][Full Text] [Related]
17. Risk factors of early thyroid dysfunction after definitive radiotherapy in nasopharyngeal carcinoma patients.
Lian CL; Zhuo RG; Zhou R; Yu YF; Zhou P; Lin Q; Wu SG
Head Neck; 2023 Sep; 45(9):2344-2354. PubMed ID: 37415457
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of clinical hypothyroidism risk due to irradiation of thyroid and pituitary glands in radiotherapy of nasopharyngeal cancer patients.
Lin Z; Wang X; Xie W; Yang Z; Che K; Wu VW
J Med Imaging Radiat Oncol; 2013 Dec; 57(6):713-8. PubMed ID: 24283561
[TBL] [Abstract][Full Text] [Related]
19. Dose-volume histogram prediction in volumetric modulated arc therapy for nasopharyngeal carcinomas based on uniform-intensity radiation with equal angle intervals.
Zhuang Y; Han J; Chen L; Liu X
Phys Med Biol; 2019 Dec; 64(23):23NT03. PubMed ID: 31683261
[TBL] [Abstract][Full Text] [Related]
20. Hypothalamic-pituitary-thyroid dysfunction induced by intensity-modulated radiotherapy (IMRT) for adult patients with nasopharyngeal carcinoma.
Huang S; Wang X; Hu C; Ying H
Med Oncol; 2013 Dec; 30(4):710. PubMed ID: 23999842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
